The November 22, 2007 issue of The Economist contains a story on nanotechnology safety entitled "A little risky business."   The article focuses on Andrew Maynard’s presentation before the House Science Commitee in October, an event we covered here, and also covers the ongoing debate over the use of silver nanoparticles as an antimicrobial agent in consumer … Continue Reading